Monday, March 20, 2017 9:58:14 PM
I have a few friends with it and while they're in remission, they are monitored frequently, just as I am for leukemia. The treatment is different, but both have the potential of coming out of remission after years. I look forward to advances, but hopefully they are not needed for me or my friends.
As I understand the MM drug, it supplements existing treatment but doesn't have benefits by itself. The FDA usually wants monotherapy trials before permitting combined use. This may be awkward as volunteers would know that they're getting no benefit. The company might be smarter with trials in Israel that aren't sanctioned by the FDA until the FDA has seen data worthy of combined trials.
Of course it's possible that Trump will change the way the FDA operates, at least that's one thing I could agree with him about.
Gary
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM